24 March 2011

New wider blood cancer pictures taken

Scientists published the broadest picture of the likely genetic causes of multiple myeloma, a common blood cancer in which malignant white blood cells proliferate unchecked.


Scientists published the broadest picture yet of the likely genetic causes of multiple myeloma, a common form of blood cancer in which malignant white blood cells proliferate unchecked.

The map comes courtesy of a trawl through the DNA of 38 people with the disease, according to the research carried out by 21 institutions in North America.

White blood cells develop in the bone marrow and make antibodies that help the immune system fight microbes. Multiple myeloma cripples these defences, leaving victims dangerously exposed to infections.

The survival rate is poor compared to other cancers. About 20,000 new cases are diagnosed in the US each year, and fewer than 40% survive to five years.

Genomic sequencing entails looking through the DNA code for tiny variations that could explain why some people are at risk of disease while others are not.

Help finding the cause of malignancy

The cost of sequencing has fallen sharply in recent years, which means researchers are able to cast their net wider than before. Previous studies into multiple myeloma have been able to look only at the DNA of a single patient.

"For the first time we are able to see on a molecular basis what might be causing this malignancy," said David Siegel of the John Theurer Cancer Centre at Hackensack University, New Jersey.

"We already know what causes many types of cancer, but until now we had few clues to the causes of myeloma."

A preliminary analysis of the DNA variations suggests there are common pathways, especially in the cellular protein-making machine, that enable a malignant cell to survive, invade and spread.

The initial benefit from this is, understanding more about the basics of multiple myeloma.

Future hopes

Eventually, doctors hope, it will lead to drugs to block the disease.

"It's going to take a lot of biological research to sort out whether these will make good drug targets," said Todd Golub, director of the cancer programme at the Broad Institute of Harvard University and the Massachusetts Institute of Technology (MIT).

"But this is an example of how genetic analysis can help point the field in the right direction very dramatically."

The study appears in Nature, the British science journal.

(Sapa, March 2011)

Read more:

Visit our cancer centre


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst and Head of Advocacy Magdalene Seguin. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules